Sompo Japan and MACP Launch Collaboration in Medical Succession Consulting – Biz/Zine

News Highlights

Sompo Japan Insurance Inc. (Sompo Japan) and MACP (Medical Asset Consulting Partners), a consulting firm specializing in M&A for medical institutions, have begun collaborating in the field of medical succession consulting. This partnership aims to present third-party succession as an alternative to closure or廃業 (haigyō – ceasing business) for medical institutions facing successor issues, encouraging early consideration. Sompo Japan will leverage its extensive network and customer base, while MACP will utilize its specialized knowledge and consulting capabilities in the medical field to support the matching of medical institutions wishing to undergo succession with potential buyers.

M&A Medical Editorial Department’s Perspective

The collaboration between Sompo Japan and MACP suggests the entry of new players into the medical succession market and an evolution in their approach. In particular, Sompo Japan’s ability to approach non-medical companies may promote entry from different industries that have not previously been considered as buyers in medical M&A. For example, a scheme could involve companies operating elderly care facilities or providing healthcare-related services acquiring management rights of medical institutions through M&A. MACP’s expertise will enable matching that considers the specific regulations and characteristics of medical practices, realizing successions that go beyond mere business transfer to include added value such as business revitalization or diversification. This collaboration will provide medical institutions struggling with a lack of successors with more diverse options and professional support.

Points Raised by This News

• Sompo Japan’s extensive network has the potential to create buyer candidates for medical institution M&A from different industries.
• MACP’s expertise will support the construction of optimal succession schemes tailored to the individual circumstances of medical institutions.
• The options for third-party succession will expand, lowering the hurdle for solving successor issues.
• Qualitative improvement in medical succession support is expected through the collaboration between financial institutions and specialized consultants.

Practical Questions Arising from This News

• Specifically, to which medical institution clients will Sompo Japan approach?
• What kind of due diligence and integration support will MACP’s specialized team provide to buyers from different industries?
• Through this collaboration, what scale and types of medical institutions are envisioned for succession?

If You Feel “Should I Consult Too?”

If your institution is experiencing concerns about a lack of successors or business continuity, this news suggests the existence of new options. Those particularly interested in matching with buyers from different industries or in detailed support from experts may find it worthwhile to consider consulting with an M&A specialist. We recommend organizing your institution’s current situation and future vision, and gathering information on the possibilities and specific procedures for third-party succession.

M&A Medical (CentralMedience Inc.) is an M&A support institution certified by the Small and Medium Enterprise Agency, providing support for the business succession of medical corporations, hospitals, and clinics on a full success fee basis. Consultations are accepted with strict confidentiality. Free consultations here.